Segment Reporting - Summary Of Significant Expense Categories For The Segment (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Segment Reporting | ||||||
| External research and development costs | [1] | $ 50,065 | $ 22,547 | $ 86,118 | $ 42,570 | |
| Loss from operations | (58,916) | (27,778) | (102,361) | (51,162) | ||
| Operating Segments | ||||||
| Segment Reporting | ||||||
| Research and development personnel-related costs (including stock-based compensation) | 16,775 | 5,710 | 27,423 | 9,662 | ||
| Other research and development costs | 2,103 | 306 | 3,286 | 723 | ||
| General and administrative personnel-related costs (including stock-based compensation) | 5,687 | 3,118 | 10,985 | 4,827 | ||
| General and administrative professional, consulting, and other fees | 3,164 | 2,113 | 5,258 | 3,765 | ||
| Loss from operations | 58,916 | 27,778 | 102,361 | 51,162 | ||
| JADE101 | Operating Segments | ||||||
| Segment Reporting | ||||||
| External research and development costs | 14,978 | 7,249 | 30,401 | 17,016 | ||
| JADE201 | Operating Segments | ||||||
| Segment Reporting | ||||||
| External research and development costs | 6,104 | 8,356 | 8,981 | 13,510 | ||
| JADE301 | Operating Segments | ||||||
| Segment Reporting | ||||||
| External research and development costs | $ 10,105 | $ 926 | $ 16,027 | $ 1,659 | ||
| ||||||
| X | ||||||||||
- Definition Research and development personnel-related costs (including stock-based compensation) No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|